TB Screening Improves Preventive Therapy Uptake (TB SCRIPT)
Tuberculosis, Latent Tuberculosis, Tuberculosis Prevention
About this trial
This is an interventional screening trial for Tuberculosis focused on measuring Tuberculosis, Latent tuberculosis, Tuberculosis preventive therapy, HIV, C-reactive protein, Symptom screening, Intensified case finding
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years
- Confirmed HIV+ test result
- CD4 T lymphocyte count of ≤ 350 cells/μL
- Capacity to provide written (or witnessed verbal, if illiterate) informed consent
Exclusion Criteria:
- Completed treatment for active pulmonary or extra-pulmonary TB within the past 2 years
- Completed a full course of TPT within the past year
- Actively taking any internationally-approved medication for TB treatment for any reason, within 2 weeks of study entry
- Prior history of combined ART for HIV treatment for any duration (does not include single-dose ART for prevention of vertical transmission of HIV)
- Currently resides 25 km outside their enrollment site, plans to move 25 km outside their enrollment site in the next 2 years, or plans to transfer their HIV care from their current enrollment site
Sites / Locations
- Kampala Capital City Authority ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
POC CRP-based TB screening
Symptom-based TB screening
Participants randomized to the intervention arm will undergo POC CRP-based TB screening at study entry. Participants with elevated POC CRP levels (≥8 mg/L) will be regarded as screen-positive and will be referred for confirmatory TB testing. Participants with non-elevated POC CRP levels (<8 mg/L) will be regarded as screen-negative and will be assessed for TPT eligibility.
Participants randomized to the control arm will undergo symptom-based TB screening at study entry. Participants reporting ≥1 TB symptom (current cough, fever, night sweats, weight loss) will be regarded as screen-positive and will be referred for confirmatory TB testing, in accordance with WHO guidelines. Participants with none of the 4 TB symptoms will be regarded as screen-negative and will be assessed for TPT eligibility.